Abstract
Purpose
CaCo-2 colon cancer cells and HepG2 liver cancer cells represent two malignant cell lines, which show a high resistance to apoptosis induced by the conventional anticancer drugs. Vitexin-2-O-xyloside (XVX) and avenanthramides (AVNs) are naturally occurring dietary agents from Beta vulgaris var. cicla L. and Avena sativa L., respectively. The aim of this work was to evaluate the antiproliferative effects and the reduction of the pro-survival mechanisms exerted by XVX and AVNs, used individually and in combination, in CaCo-2 and HepG2 cancer cells.
Methods
XVX and AVNs were isolated by liquid chromatography and characterized by HPLC–PDA–MS. The XVX and AVN antiproliferative effects were evaluated through sulforhodamine B method, while their pro-apoptotic effects through caspase activity assays. RTqPCR was used to investigate the modulation of the pro-survival factors baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5), hypoxia inducible factor 1 A (HIF1A), and vascular endothelial growth factor A (VEGFA). Cellular antioxidant activity (CAA) was investigated by means of DCFH-DA assay, whereas chemical antioxidant capacity was evaluated by the ORAC method.
Results
XVX and AVNs, both individually and in combination, inhibited the proliferation of CaCo-2 and HepG2 cancer cells, through activation of caspases 9, 8, and 3. XVX and AVNs downregulated the pro-survival genes BIRC5, HIF1A, and VEGFA. The CAA assay showed that AVNs exhibited strong antioxidant activity inside both CaCo-2 and HepG2 cells.
Conclusions
The antiproliferative activity of the XVX + AVNs mixture represents an innovative treatment, which is effective against two types of cancer cells characterized by high resistance to the conventional anticancer drugs.
Similar content being viewed by others
Abbreviations
- AVNs:
-
Avenanthramides
- BIRC5:
-
Baculoviral inhibitor of apoptosis repeat-containing 5
- BVc:
-
Beta vulgaris var. cicla L.
- CAA:
-
Cellular antioxidant activity
- DCFH-DA:
-
2′,7′-Dichlorodihydrofluorescein diacetate
- HIF1A:
-
Hypoxia inducible factor 1 A
- HPLC:
-
High pressure liquid chromatography
- IAPs:
-
Inhibitor of apoptosis proteins
- MS:
-
Mass spectrometry
- NAC:
-
N-Acetyl cysteine
- ORAC:
-
Oxygen radical absorbance capacity
- PDA:
-
Photo diode array
- SRB:
-
Sulforhodamine B
- UV:
-
Ultraviolet
- VEGF:
-
Vascular endothelial growth factor
- XVX:
-
Vitexin-2-O-xyloside
References
Ninfali P, Bacchiocca M, Antonelli A, Biagiotti E, Di Gioacchino AM, Piccoli G, Stocchi V, Brandi G (2007) Characterization and biological activity of the main flavonoids from Swiss Chard (Beta vulgaris subspecies cycla). Phytomedicine 14:216–221
Ninfali P, Angelino D (2013) Nutritional and functional potential of Beta vulgaris cicla and rubra. Fitoterapia 89:188–199
Gennari L, Felletti M, Blasa M, Angelino D, Celeghini C, Corallini A, Ninfali P (2011) Total extract of Beta vulgaris var. cicla seeds versus its purified phenolic components: antioxidant activities and antiproliferative effects against colon cancer cells. Phytochem Anal 22:272–279
Papi A, Farabegoli F, Iori R, Orlandi M, De Nicola GR, Bagatta M, Angelino D, Gennari L, Ninfali P (2013) Vitexin-2-0-xyloside, raphasatin and (–)-epigallocatechin-3-gallate synergistically affect cell growth and apoptosis of colon cancer cells. Food Chem 138:1521–1530
Farabegoli F, Scarpa ES, Frati A, Serafini G, Papi A, Spisni E, Antonini E, Benedetti S, Ninfali P (2017) Betalains increase vitexin-2-O-xyloside cytotoxicity in CaCo-2 cancer cells. Food Chem 218:356–364
Peterson DM (2001) Oat antioxidants. J Cereal Sci 33:115–129
Collins FW (1989) Oat phenolics: avenanthramides, novel substituted N-cinnamoylanthranilate alkaloids from oat groats and hulls. J Agric Food Chem 37:60–66
Antonini E, Lombardi F, Alfieri M, Diamantini G, Redaelli R, Ninfali P (2016) Nutritional characterization of naked and dehulled oat cultivar samples at harvest and after storage. J Cereal Sci 72:46–53
Skoglund M, Peterson DM, Andersson R, Nilsson J, Dimberg LH (2008) Avenanthramide content and related enzyme activities in oats as affected by steeping and germination. J Cereal Sci 48:294–303
Xu JG, Tian CR, Hu QP, Luo JY, Wang XD, Tian XD (2009) Dynamic changes in phenolic compounds and antioxidant activity in oats (Avena nuda L.) during steeping and germination. J Agric Food Chem 57:10392–10398
Chen CY, Milbury PE, Kwak HK, Collins FW, Samuel P, Blumberg JB (2004) Avenanthramides and phenolic acids from oats are bioavailable and act synergistically with vitamin C to enhance hamster and human LDL resistance to oxidation. J Nutr 134:1459–1466
Chen CYO, Milbury PE, Collins FW, Blumberg JB (2007) Avenanthramides are bioavailable and have antioxidant activity in humans after acute consumption of an enriched mixture from oats. J Nutr 137:1375–1382
Koenig RT, Dickman JR, Wise ML, Ji LL (2011) Avenanthramides are bioavailable and accumulate in hepatic, cardiac, and skeletal muscle tissue following oral gavage in rats. J Agric Food Chem 59:6438–6443
Meydani M (2009) Potential health benefits of avenanthramides of oats. Nutr Rev 67:731–735
Guo WM, Nie L, Wu DY, Wise ML, Collins FW, Meydani SN, Meydani M (2010) Avenanthramides inhibit proliferation of human colon cancer cell lines in vitro. Nutr Cancer 62:1007–1016
Holdenrieder S, Stieber P (2004) Apoptotic markers in cancer. Clin Biochem 37:605–617
Samali A, Jager R (2014) Mechanisms of resistance to cell death pathways in cancer cells. In: McManus LM, Mitchell RN (eds) Pathobiology of human disease, 1st edn. Elsevier Inc., Atlanta, pp 393–402
Altieri DC (2013) Targeting survivin in cancer. Cancer Lett 332:225–228
Johnson ME, Howerth EW (2004) Survivin: a bifunctional inhibitor of apoptosis protein. Vet Pathol 41:599–607
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Gomez-Roman N, Sahasrabudhe NM, McGregor F, Chalmers AJ, Cassidy J, Plumb J (2016) Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer. Oncotarget 7:22650–22664
Brahimi-Horn MC, Chiche J, Pouyssegur J (2007) Hypoxia and cancer. J Mol Med 85:1301–1307
Wang GL, Jiang BH, Rue EA, Semenza GL (1995) Hypoxia-inducible factor-1 is a basic-helix–loop–helix-pas heterodimer regulated by cellular O-2 tension. Proc Natl Acad Sci USA 92:5510–5514
Baba Y, Nosho K, Shima K, Irahara N, Chan AT, Meyerhardt JA, Chung DC, Giovannucci EL, Fuchs CS, Ogino S (2010) HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. Am J Pathol 176:2292–2301
Ferrara N (2005) VEGF as a therapeutic target in cancer. Int Soc Cell 69:11–16
Ellis LM, Takahashi Y, Liu W, Shaheen RM (2000) Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications. Oncologist 5:11–15
Doll JA, Hobbs JE, Soff JA (2007) Role of apoptosis in anti-angiogenic cancer therapies. In: Gewirtz DA, Holt SE, Grant S (eds) Apoptosis and senescence in cancer chemotherapy and radiotherapy, 2nd edn. Humana Press, Totowa, pp 537–555
Piccirillo S, Filomeni G, Brune B, Rotilio G, Ciriolo MR (2009) Redox mechanisms involved in the selective activation of Nrf2-mediated resistance versus p53-dependent apoptosis in adenocarcinoma cells. J Biol Chem 284:27721–27733
Heo SH, Kwak J, Jang KL (2015) All-trans retinoic acid induces p53-dependent apoptosis in human hepatocytes by activating p14 expression via promoter hypomethylation. Cancer Lett 362:139–148
Ye RP, Chen ZD (2017) Saikosaponin A, an active glycoside from Radix bupleuri, reverses P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cells and HepG2/ADM cells. Xenobiotica 47:176–184
Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592
Liu LP, Zubik L, Collins FW, Marko M, Meydani M (2004) The antiatherogenic potential of oat phenolic compounds. Atherosclerosis 175:39–49
Ninfali P, Gennari L, Biagiotti E, Cangi F, Mattoli L, Maidecchi A (2009) Improvement in botanical standardization of commercial freeze-dried herbal extracts by using the combination of antioxidant capacity and constituent marker concentrations. J AOAC Int 92:797–805
Wang Y, Tang Q, Jiang S, Li M, Wang X (2013) Anti-colorectal cancer activity of macrostemonoside A mediated by reactive oxygen species. Biochem Biophys Res Commun 441:825–830
Scarpa ES, Emanuelli M, Frati A, Pozzi V, Antonini E, Diamantini G, Di RG, Sartini D, Armeni T, Palma F, Ninfali P (2016) Betacyanins enhance vitexin-2-O-xyloside mediated inhibition of proliferation of T24 bladder cancer cells. Food Funct 7:4772–4780
Peterson DM, Hahn MJ, Emmons CL (2002) Oat avenanthramides exhibit antioxidant activities in vitro. Food Chem 79:473–478
Khan N, Adhami VM, Mukhtar H (2008) Apoptosis by dietary agents for prevention and treatment of cancer. Biochem Pharmacol 76:1333–1339
Huang H, Chen AY, Rojanasakul Y, Ye X, Rankin GO, Chen YC (2015) Dietary compounds galangin and myricetin suppress ovarian cancer cell angiogenesis. J Funct Foods 15:464–475
Angelino D, Berhow M, Ninfali P, Jeffery EH (2013) Caecal absorption of vitexin-2-O-xyloside and its aglycone apigenin, in the rat. Food Funct 4:1339–1345
Gorrini C, Harris IS, Mak TW (2013) Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov 12:931–947
Arbiser JL, Petros J, Klafter R, Govindajaran B, McLaughlin ER, Brown LF, Cohen C, Moses M, Kilroy S, Arnold RS, Lambeth JD (2002) Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc Natl Acad Sci USA 99:715–720
Zhang Y, Zhao W, Zhang HJ, Domann FE, Oberley LW (2002) Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth. Cancer Res 62:1205–1212
Ueda S, Nakamura H, Masutani H, Sasada T, Takabayashi A, Yamaoka Y, Yodoi J (2002) Baicalin induces apoptosis via mitochondrial pathway as prooxidant. Mol Immunol 38:781–791
Ismail N, Alam M (2001) A novel cytotoxic flavonoid glycoside from Physalis angulata. Fitoterapia 72:676–679
Cao G, Sofic E, Prior RL (1997) Antioxidant and prooxidant behavior of flavonoids: structure–activity relationships. Free Radic Biol Med 22:749–760
Choi HJ, Eun JS, Kim BG, Kim SY, Jeon H, Soh Y (2006) Vitexin, an HIF-1alpha inhibitor, has anti-metastatic potential in PC12 cells. Mol Cells 22:291–299
Ma J, Feng Y, Liu Y, Li X (2016) PUMA and survivin are involved in the apoptosis of HepG2 cells induced by microcystin-LR via mitochondria-mediated pathway. Chemosphere 157:241–249
Harris IS, Brugge JS (2015) Cancer: the enemy of my enemy is my friend. Nature 527:170–171
Acknowledgements
We acknowledge the financial support of University of Urbino “Carlo Bo”. The authors wish also to thank: Terra Bio Soc. Coop. (Urbino, Italy) and Suba Seeds Company S.p.A. (Longiano, Italy) for providing oat grains and Beta vulgaris var. cicla L. seeds, respectively. Timothy Bloom is acknowledged for assistance in the English language.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Scarpa, E.S., Antonini, E., Palma, F. et al. Antiproliferative activity of vitexin-2-O-xyloside and avenanthramides on CaCo-2 and HepG2 cancer cells occurs through apoptosis induction and reduction of pro-survival mechanisms. Eur J Nutr 57, 1381–1395 (2018). https://doi.org/10.1007/s00394-017-1418-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-017-1418-y